Skip to main content
NCBI home page
Mediators of Inflammation logoLink to Mediators of Inflammation
. 1998;7(4):229–237. doi: 10.1080/09629359890910

Glucocorticoids: mechanisms of action and anti-inflammatory potential in asthma.

V H van der Velden 1
PMCID: PMC1781857  PMID: 9792333

Abstract

GLUCOCORTICOIDS are potent inhibitors of inflammatory processes and are widely used in the treatment of asthma. The anti-inflammatory effects are mediated either by direct binding of the glucocorticoid/glucocorticoid receptor complex to glucocorticoid responsive elements in the promoter region of genes, or by an interaction of this complex with other transcription factors, in particular activating protein-1 or nuclear factor-kappaB. Glucocorticoids inhibit many inflammation-associated molecules such as cytokines, chemokines, arachidonic acid metabolites, and adhesion molecules. In contrast, anti-inflammatory mediators often are up-regulated by glucocorticoids. In vivo studies have shown that treatment of asthmatic patients with inhaled glucocorticoids inhibits the bronchial inflammation and simultaneously improves their lung function. In this review, our current knowledge of the mechanism of action of glucocorticoids and their anti-inflammatory potential in asthma is described. Since bronchial epithelial cells may be important targets for glucocorticoid therapy in asthma, the effects of glucocorticoids on epithelial expressed inflammatory genes will be emphasized.

Full Text

The Full Text of this article is available as a PDF (289.1 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Abbinante-Nissen J. M., Simpson L. G., Leikauf G. D. Corticosteroids increase secretory leukocyte protease inhibitor transcript levels in airway epithelial cells. Am J Physiol. 1995 Apr;268(4 Pt 1):L601–L606. doi: 10.1152/ajplung.1995.268.4.L601. [DOI] [PubMed] [Google Scholar]
  2. Adcock I. M., Brown C. R., Kwon O., Barnes P. J. Oxidative stress induces NF kappa B DNA binding and inducible NOS mRNA in human epithelial cells. Biochem Biophys Res Commun. 1994 Mar 30;199(3):1518–1524. doi: 10.1006/bbrc.1994.1403. [DOI] [PubMed] [Google Scholar]
  3. Adcock I. M., Gilbey T., Gelder C. M., Chung K. F., Barnes P. J. Glucocorticoid receptor localization in normal and asthmatic lung. Am J Respir Crit Care Med. 1996 Sep;154(3 Pt 1):771–782. doi: 10.1164/ajrccm.154.3.8810618. [DOI] [PubMed] [Google Scholar]
  4. Adcock I. M., Peters M. J., Brown C. R., Stevens D. A., Barnes P. J. High concentrations of beta-adrenergic agonists inhibit DNA binding of glucocorticoids in human lung in vitro. Biochem Soc Trans. 1995 May;23(2):217S–217S. doi: 10.1042/bst023217s. [DOI] [PubMed] [Google Scholar]
  5. Adcock I. M., Stevens D. A., Barnes P. J. Interactions of glucocorticoids and beta 2-agonists. Eur Respir J. 1996 Jan;9(1):160–168. doi: 10.1183/09031936.96.09010160. [DOI] [PubMed] [Google Scholar]
  6. Adelroth E., Rosenhall L., Johansson S. A., Linden M., Venge P. Inflammatory cells and eosinophilic activity in asthmatics investigated by bronchoalveolar lavage. The effects of antiasthmatic treatment with budesonide or terbutaline. Am Rev Respir Dis. 1990 Jul;142(1):91–99. doi: 10.1164/ajrccm/142.1.91. [DOI] [PubMed] [Google Scholar]
  7. Angel P., Karin M. The role of Jun, Fos and the AP-1 complex in cell-proliferation and transformation. Biochim Biophys Acta. 1991 Dec 10;1072(2-3):129–157. doi: 10.1016/0304-419x(91)90011-9. [DOI] [PubMed] [Google Scholar]
  8. Auphan N., DiDonato J. A., Rosette C., Helmberg A., Karin M. Immunosuppression by glucocorticoids: inhibition of NF-kappa B activity through induction of I kappa B synthesis. Science. 1995 Oct 13;270(5234):286–290. doi: 10.1126/science.270.5234.286. [DOI] [PubMed] [Google Scholar]
  9. Azzawi M., Bradley B., Jeffery P. K., Frew A. J., Wardlaw A. J., Knowles G., Assoufi B., Collins J. V., Durham S., Kay A. B. Identification of activated T lymphocytes and eosinophils in bronchial biopsies in stable atopic asthma. Am Rev Respir Dis. 1990 Dec;142(6 Pt 1):1407–1413. doi: 10.1164/ajrccm/142.6_Pt_1.1407. [DOI] [PubMed] [Google Scholar]
  10. Bai T. R., Zhou D., Weir T., Walker B., Hegele R., Hayashi S., McKay K., Bondy G. P., Fong T. Substance P (NK1)- and neurokinin A (NK2)-receptor gene expression in inflammatory airway diseases. Am J Physiol. 1995 Sep;269(3 Pt 1):L309–L317. doi: 10.1152/ajplung.1995.269.3.L309. [DOI] [PubMed] [Google Scholar]
  11. Barnes P. J. Effect of corticosteroids on airway hyperresponsiveness. Am Rev Respir Dis. 1990 Feb;141(2 Pt 2):S70–S76. [PubMed] [Google Scholar]
  12. Barnes P. J. Endothelins and pulmonary diseases. J Appl Physiol (1985) 1994 Sep;77(3):1051–1059. doi: 10.1152/jappl.1994.77.3.1051. [DOI] [PubMed] [Google Scholar]
  13. Barnes P. J. Molecular mechanisms of steroid action in asthma. J Allergy Clin Immunol. 1996 Jan;97(1 Pt 2):159–168. doi: 10.1016/s0091-6749(96)80216-8. [DOI] [PubMed] [Google Scholar]
  14. Barnes P. J. Nitric oxide and asthma. Res Immunol. 1995 Nov-Dec;146(9):698–702. doi: 10.1016/0923-2494(96)84921-2. [DOI] [PubMed] [Google Scholar]
  15. Beasley R., Roche W. R., Roberts J. A., Holgate S. T. Cellular events in the bronchi in mild asthma and after bronchial provocation. Am Rev Respir Dis. 1989 Mar;139(3):806–817. doi: 10.1164/ajrccm/139.3.806. [DOI] [PubMed] [Google Scholar]
  16. Beato M. Gene regulation by steroid hormones. Cell. 1989 Feb 10;56(3):335–344. doi: 10.1016/0092-8674(89)90237-7. [DOI] [PubMed] [Google Scholar]
  17. Becker P., Renkawitz R., Schütz G. Tissue-specific DNaseI hypersensitive sites in the 5'-flanking sequences of the tryptophan oxygenase and the tyrosine aminotransferase genes. EMBO J. 1984 Sep;3(9):2015–2020. doi: 10.1002/j.1460-2075.1984.tb02084.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  18. Bentley A. M., Hamid Q., Robinson D. S., Schotman E., Meng Q., Assoufi B., Kay A. B., Durham S. R. Prednisolone treatment in asthma. Reduction in the numbers of eosinophils, T cells, tryptase-only positive mast cells, and modulation of IL-4, IL-5, and interferon-gamma cytokine gene expression within the bronchial mucosa. Am J Respir Crit Care Med. 1996 Feb;153(2):551–556. doi: 10.1164/ajrccm.153.2.8564096. [DOI] [PubMed] [Google Scholar]
  19. Berkman N., Robichaud A., Krishnan V. L., Roesems G., Robbins R., Jose P. J., Barnes P. J., Chung K. F. Expression of RANTES in human airway epithelial cells: effect of corticosteroids and interleukin-4, -10 and -13. Immunology. 1996 Apr;87(4):599–603. doi: 10.1046/j.1365-2567.1996.477579.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  20. Berkman N., Robichaud A., Robbins R. A., Roesems G., Haddad E. B., Barnes P. J., Chung K. F. Inhibition of inducible nitric oxide synthase expression by interleukin-4 and interleukin-13 in human lung epithelial cells. Immunology. 1996 Nov;89(3):363–367. doi: 10.1046/j.1365-2567.1996.d01-745.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  21. Booth H., Richmond I., Ward C., Gardiner P. V., Harkawat R., Walters E. H. Effect of high dose inhaled fluticasone propionate on airway inflammation in asthma. Am J Respir Crit Care Med. 1995 Jul;152(1):45–52. doi: 10.1164/ajrccm.152.1.7599861. [DOI] [PubMed] [Google Scholar]
  22. Borson D. B., Gruenert D. C. Glucocorticoids induce neutral endopeptidase in transformed human tracheal epithelial cells. Am J Physiol. 1991 Feb;260(2 Pt 1):L83–L89. doi: 10.1152/ajplung.1991.260.2.L83. [DOI] [PubMed] [Google Scholar]
  23. Boschetto P., Rogers D. F., Fabbri L. M., Barnes P. J. Corticosteroid inhibition of airway microvascular leakage. Am Rev Respir Dis. 1991 Mar;143(3):605–609. doi: 10.1164/ajrccm/143.3.605. [DOI] [PubMed] [Google Scholar]
  24. Bousquet J., Chanez P., Lacoste J. Y., Barnéon G., Ghavanian N., Enander I., Venge P., Ahlstedt S., Simony-Lafontaine J., Godard P. Eosinophilic inflammation in asthma. N Engl J Med. 1990 Oct 11;323(15):1033–1039. doi: 10.1056/NEJM199010113231505. [DOI] [PubMed] [Google Scholar]
  25. Burge P. S. The effects of corticosteroids on the immediate asthmatic reaction. Eur J Respir Dis Suppl. 1982;122:163–166. [PubMed] [Google Scholar]
  26. Burke C., Power C. K., Norris A., Condez A., Schmekel B., Poulter L. W. Lung function and immunopathological changes after inhaled corticosteroid therapy in asthma. Eur Respir J. 1992 Jan;5(1):73–79. [PubMed] [Google Scholar]
  27. Bédard M., McClure C. D., Schiller N. L., Francoeur C., Cantin A., Denis M. Release of interleukin-8, interleukin-6, and colony-stimulating factors by upper airway epithelial cells: implications for cystic fibrosis. Am J Respir Cell Mol Biol. 1993 Oct;9(4):455–462. doi: 10.1165/ajrcmb/9.4.455. [DOI] [PubMed] [Google Scholar]
  28. CARRYER H. M., KOELSCHE G. A., PRICKMAN L. E., MAYTUM C. K., LAKE C. F., WILLIAMS H. L. Effects of cortisone on bronchial asthma and hay fever occurring in subjects sensitive to ragweed pollen. Proc Staff Meet Mayo Clin. 1950 Aug 16;25(17):482–486. [PubMed] [Google Scholar]
  29. Caldenhoven E., Liden J., Wissink S., Van de Stolpe A., Raaijmakers J., Koenderman L., Okret S., Gustafsson J. A., Van der Saag P. T. Negative cross-talk between RelA and the glucocorticoid receptor: a possible mechanism for the antiinflammatory action of glucocorticoids. Mol Endocrinol. 1995 Apr;9(4):401–412. doi: 10.1210/mend.9.4.7659084. [DOI] [PubMed] [Google Scholar]
  30. Clutterbuck E. J., Hirst E. M., Sanderson C. J. Human interleukin-5 (IL-5) regulates the production of eosinophils in human bone marrow cultures: comparison and interaction with IL-1, IL-3, IL-6, and GMCSF. Blood. 1989 May 1;73(6):1504–1512. [PubMed] [Google Scholar]
  31. Cockcroft D. W., Murdock K. Y. Comparative effects of inhaled salbutamol, sodium cromoglycate, and beclomethasone dipropionate on allergen-induced early asthmatic responses, late asthmatic responses, and increased bronchial responsiveness to histamine. J Allergy Clin Immunol. 1987 May;79(5):734–740. doi: 10.1016/0091-6749(87)90204-1. [DOI] [PubMed] [Google Scholar]
  32. Colotta F., Re F., Muzio M., Bertini R., Polentarutti N., Sironi M., Giri J. G., Dower S. K., Sims J. E., Mantovani A. Interleukin-1 type II receptor: a decoy target for IL-1 that is regulated by IL-4. Science. 1993 Jul 23;261(5120):472–475. doi: 10.1126/science.8332913. [DOI] [PubMed] [Google Scholar]
  33. Cox G., Ohtoshi T., Vancheri C., Denburg J. A., Dolovich J., Gauldie J., Jordana M. Promotion of eosinophil survival by human bronchial epithelial cells and its modulation by steroids. Am J Respir Cell Mol Biol. 1991 Jun;4(6):525–531. doi: 10.1165/ajrcmb/4.6.525. [DOI] [PubMed] [Google Scholar]
  34. Cronstein B. N., Kimmel S. C., Levin R. I., Martiniuk F., Weissmann G. A mechanism for the antiinflammatory effects of corticosteroids: the glucocorticoid receptor regulates leukocyte adhesion to endothelial cells and expression of endothelial-leukocyte adhesion molecule 1 and intercellular adhesion molecule 1. Proc Natl Acad Sci U S A. 1992 Nov 1;89(21):9991–9995. doi: 10.1073/pnas.89.21.9991. [DOI] [PMC free article] [PubMed] [Google Scholar]
  35. Dahl R., Johansson S. A. Importance of duration of treatment with inhaled budesonide on the immediate and late bronchial reaction. Eur J Respir Dis Suppl. 1982;122:167–175. [PubMed] [Google Scholar]
  36. Davis M. M., Bjorkman P. J. T-cell antigen receptor genes and T-cell recognition. Nature. 1988 Aug 4;334(6181):395–402. doi: 10.1038/334395a0. [DOI] [PubMed] [Google Scholar]
  37. Dawes K. E., Cambrey A. D., Campa J. S., Bishop J. E., McAnulty R. J., Peacock A. J., Laurent G. J. Changes in collagen metabolism in response to endothelin-1: evidence for fibroblast heterogeneity. Int J Biochem Cell Biol. 1996 Feb;28(2):229–238. doi: 10.1016/1357-2725(95)00124-7. [DOI] [PubMed] [Google Scholar]
  38. Didonato J. A., Saatcioglu F., Karin M. Molecular mechanisms of immunosuppression and anti-inflammatory activities by glucocorticoids. Am J Respir Crit Care Med. 1996 Aug;154(2 Pt 2):S11–S15. doi: 10.1164/ajrccm/154.2_Pt_2.S11. [DOI] [PubMed] [Google Scholar]
  39. Djukanović R., Homeyard S., Gratziou C., Madden J., Walls A., Montefort S., Peroni D., Polosa R., Holgate S., Howarth P. The effect of treatment with oral corticosteroids on asthma symptoms and airway inflammation. Am J Respir Crit Care Med. 1997 Mar;155(3):826–832. doi: 10.1164/ajrccm.155.3.9117012. [DOI] [PubMed] [Google Scholar]
  40. Djukanović R., Roche W. R., Wilson J. W., Beasley C. R., Twentyman O. P., Howarth R. H., Holgate S. T. Mucosal inflammation in asthma. Am Rev Respir Dis. 1990 Aug;142(2):434–457. doi: 10.1164/ajrccm/142.2.434. [DOI] [PubMed] [Google Scholar]
  41. Djukanović R., Wilson J. W., Britten K. M., Wilson S. J., Walls A. F., Roche W. R., Howarth P. H., Holgate S. T. Effect of an inhaled corticosteroid on airway inflammation and symptoms in asthma. Am Rev Respir Dis. 1992 Mar;145(3):669–674. doi: 10.1164/ajrccm/145.3.669. [DOI] [PubMed] [Google Scholar]
  42. Djukanović R., Wilson J. W., Britten K. M., Wilson S. J., Walls A. F., Roche W. R., Howarth P. H., Holgate S. T. Quantitation of mast cells and eosinophils in the bronchial mucosa of symptomatic atopic asthmatics and healthy control subjects using immunohistochemistry. Am Rev Respir Dis. 1990 Oct;142(4):863–871. doi: 10.1164/ajrccm/142.4.863. [DOI] [PubMed] [Google Scholar]
  43. Dower S. K., Fanslow W., Jacobs C., Waugh S., Sims J. E., Widmer M. B. Interleukin-I antagonists. Ther Immunol. 1994 Apr;1(2):113–122. [PubMed] [Google Scholar]
  44. Duddridge M., Ward C., Hendrick D. J., Walters E. H. Changes in bronchoalveolar lavage inflammatory cells in asthmatic patients treated with high dose inhaled beclomethasone dipropionate. Eur Respir J. 1993 Apr;6(4):489–497. [PubMed] [Google Scholar]
  45. Encío I. J., Detera-Wadleigh S. D. The genomic structure of the human glucocorticoid receptor. J Biol Chem. 1991 Apr 15;266(11):7182–7188. [PubMed] [Google Scholar]
  46. Erjefält I., Persson C. G. Anti-asthma drugs attenuate inflammatory leakage of plasma into airway lumen. Acta Physiol Scand. 1986 Dec;128(4):653–654. doi: 10.1111/j.1748-1716.1986.tb08027.x. [DOI] [PubMed] [Google Scholar]
  47. Evans R. M., Hollenberg S. M. Cooperative and positional independent trans-activation domains of the human glucocorticoid receptor. Cold Spring Harb Symp Quant Biol. 1988;53(Pt 2):813–818. doi: 10.1101/sqb.1988.053.01.092. [DOI] [PubMed] [Google Scholar]
  48. Evans R. M. The steroid and thyroid hormone receptor superfamily. Science. 1988 May 13;240(4854):889–895. doi: 10.1126/science.3283939. [DOI] [PMC free article] [PubMed] [Google Scholar]
  49. Finco T. S., Baldwin A. S. Mechanistic aspects of NF-kappa B regulation: the emerging role of phosphorylation and proteolysis. Immunity. 1995 Sep;3(3):263–272. doi: 10.1016/1074-7613(95)90112-4. [DOI] [PubMed] [Google Scholar]
  50. Freedman L. P. Anatomy of the steroid receptor zinc finger region. Endocr Rev. 1992 May;13(2):129–145. doi: 10.1210/edrv-13-2-129. [DOI] [PubMed] [Google Scholar]
  51. Freedman L. P., Luisi B. F., Korszun Z. R., Basavappa R., Sigler P. B., Yamamoto K. R. The function and structure of the metal coordination sites within the glucocorticoid receptor DNA binding domain. Nature. 1988 Aug 11;334(6182):543–546. doi: 10.1038/334543a0. [DOI] [PubMed] [Google Scholar]
  52. Fritton H. P., Igo-Kemenes T., Nowock J., Strech-Jurk U., Theisen M., Sippel A. E. Alternative sets of DNase I-hypersensitive sites characterize the various functional states of the chicken lysozyme gene. Nature. 1984 Sep 13;311(5982):163–165. doi: 10.1038/311163a0. [DOI] [PubMed] [Google Scholar]
  53. Gandhi C. R., Berkowitz D. E., Watkins W. D. Endothelins. Biochemistry and pathophysiologic actions. Anesthesiology. 1994 Apr;80(4):892–905. [PubMed] [Google Scholar]
  54. Geisow M. J., Walker J. H., Boustead C., Taylor W. Annexins--new family of Ca2+-regulated-phospholipid binding protein. Biosci Rep. 1987 Apr;7(4):289–298. doi: 10.1007/BF01121450. [DOI] [PubMed] [Google Scholar]
  55. Goulding N. J., Guyre P. M. Regulation of inflammation by lipocortin 1. Immunol Today. 1992 Aug;13(8):295–297. doi: 10.1016/0167-5699(92)90040-E. [DOI] [PubMed] [Google Scholar]
  56. Grilli M., Chiu J. J., Lenardo M. J. NF-kappa B and Rel: participants in a multiform transcriptional regulatory system. Int Rev Cytol. 1993;143:1–62. doi: 10.1016/s0074-7696(08)61873-2. [DOI] [PubMed] [Google Scholar]
  57. Guo F. H., De Raeve H. R., Rice T. W., Stuehr D. J., Thunnissen F. B., Erzurum S. C. Continuous nitric oxide synthesis by inducible nitric oxide synthase in normal human airway epithelium in vivo. Proc Natl Acad Sci U S A. 1995 Aug 15;92(17):7809–7813. doi: 10.1073/pnas.92.17.7809. [DOI] [PMC free article] [PubMed] [Google Scholar]
  58. Gustafsson J. A., Carlstedt-Duke J., Poellinger L., Okret S., Wikström A. C., Brönnegård M., Gillner M., Dong Y., Fuxe K., Cintra A. Biochemistry, molecular biology, and physiology of the glucocorticoid receptor. Endocr Rev. 1987 May;8(2):185–234. doi: 10.1210/edrv-8-2-185. [DOI] [PubMed] [Google Scholar]
  59. Haskill S., Beg A. A., Tompkins S. M., Morris J. S., Yurochko A. D., Sampson-Johannes A., Mondal K., Ralph P., Baldwin A. S., Jr Characterization of an immediate-early gene induced in adherent monocytes that encodes I kappa B-like activity. Cell. 1991 Jun 28;65(7):1281–1289. doi: 10.1016/0092-8674(91)90022-q. [DOI] [PubMed] [Google Scholar]
  60. Hay D. W., Hubbard W. C., Undem B. J. Endothelin-induced contraction and mediator release in human bronchus. Br J Pharmacol. 1993 Sep;110(1):392–398. doi: 10.1111/j.1476-5381.1993.tb13822.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  61. Hecht K., Carlstedt-Duke J., Stierna P., Gustafsson J., Brönnegârd M., Wikström A. C. Evidence that the beta-isoform of the human glucocorticoid receptor does not act as a physiologically significant repressor. J Biol Chem. 1997 Oct 17;272(42):26659–26664. doi: 10.1074/jbc.272.42.26659. [DOI] [PubMed] [Google Scholar]
  62. Hollenberg S. M., Giguere V., Segui P., Evans R. M. Colocalization of DNA-binding and transcriptional activation functions in the human glucocorticoid receptor. Cell. 1987 Apr 10;49(1):39–46. doi: 10.1016/0092-8674(87)90753-7. [DOI] [PubMed] [Google Scholar]
  63. Hollenberg S. M., Weinberger C., Ong E. S., Cerelli G., Oro A., Lebo R., Thompson E. B., Rosenfeld M. G., Evans R. M. Primary structure and expression of a functional human glucocorticoid receptor cDNA. Nature. 1985 Dec 19;318(6047):635–641. doi: 10.1038/318635a0. [DOI] [PMC free article] [PubMed] [Google Scholar]
  64. Inaba K., Steinman R. M. Resting and sensitized T lymphocytes exhibit distinct stimulatory (antigen-presenting cell) requirements for growth and lymphokine release. J Exp Med. 1984 Dec 1;160(6):1717–1735. doi: 10.1084/jem.160.6.1717. [DOI] [PMC free article] [PubMed] [Google Scholar]
  65. Jeffery P. K., Godfrey R. W., Adelroth E., Nelson F., Rogers A., Johansson S. A. Effects of treatment on airway inflammation and thickening of basement membrane reticular collagen in asthma. A quantitative light and electron microscopic study. Am Rev Respir Dis. 1992 Apr;145(4 Pt 1):890–899. doi: 10.1164/ajrccm/145.4_Pt_1.890. [DOI] [PubMed] [Google Scholar]
  66. Jonat C., Rahmsdorf H. J., Park K. K., Cato A. C., Gebel S., Ponta H., Herrlich P. Antitumor promotion and antiinflammation: down-modulation of AP-1 (Fos/Jun) activity by glucocorticoid hormone. Cell. 1990 Sep 21;62(6):1189–1204. doi: 10.1016/0092-8674(90)90395-u. [DOI] [PubMed] [Google Scholar]
  67. Kam J. C., Szefler S. J., Surs W., Sher E. R., Leung D. Y. Combination IL-2 and IL-4 reduces glucocorticoid receptor-binding affinity and T cell response to glucocorticoids. J Immunol. 1993 Oct 1;151(7):3460–3466. [PubMed] [Google Scholar]
  68. Keatings V. M., Jatakanon A., Worsdell Y. M., Barnes P. J. Effects of inhaled and oral glucocorticoids on inflammatory indices in asthma and COPD. Am J Respir Crit Care Med. 1997 Feb;155(2):542–548. doi: 10.1164/ajrccm.155.2.9032192. [DOI] [PubMed] [Google Scholar]
  69. Korn S. H., Wouters E. F., Wesseling G., Arends J. W., Thunnissen F. B. In vitro and in vivo modulation of alpha- and beta-glucocorticoid-receptor mRNA in human bronchial epithelium. Am J Respir Crit Care Med. 1997 Mar;155(3):1117–1122. doi: 10.1164/ajrccm.155.3.9116996. [DOI] [PubMed] [Google Scholar]
  70. Krouwels F. H., van der Heijden J. F., Lutter R., van Neerven R. J., Jansen H. M., Out T. A. Glucocorticosteroids affect functions of airway- and blood-derived human T-cell clones, favoring the Th1 profile through two mechanisms. Am J Respir Cell Mol Biol. 1996 Apr;14(4):388–397. doi: 10.1165/ajrcmb.14.4.8600944. [DOI] [PubMed] [Google Scholar]
  71. Kumar V., Chambon P. The estrogen receptor binds tightly to its responsive element as a ligand-induced homodimer. Cell. 1988 Oct 7;55(1):145–156. doi: 10.1016/0092-8674(88)90017-7. [DOI] [PubMed] [Google Scholar]
  72. Kumar V., Green S., Staub A., Chambon P. Localisation of the oestradiol-binding and putative DNA-binding domains of the human oestrogen receptor. EMBO J. 1986 Sep;5(9):2231–2236. doi: 10.1002/j.1460-2075.1986.tb04489.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  73. Kwon O. J., Au B. T., Collins P. D., Baraniuk J. N., Adcock I. M., Chung K. F., Barnes P. J. Inhibition of interleukin-8 expression by dexamethasone in human cultured airway epithelial cells. Immunology. 1994 Mar;81(3):389–394. [PMC free article] [PubMed] [Google Scholar]
  74. Kwon O. J., Jose P. J., Robbins R. A., Schall T. J., Williams T. J., Barnes P. J. Glucocorticoid inhibition of RANTES expression in human lung epithelial cells. Am J Respir Cell Mol Biol. 1995 May;12(5):488–496. doi: 10.1165/ajrcmb.12.5.7537968. [DOI] [PubMed] [Google Scholar]
  75. Laitinen L. A., Laitinen A., Haahtela T. A comparative study of the effects of an inhaled corticosteroid, budesonide, and a beta 2-agonist, terbutaline, on airway inflammation in newly diagnosed asthma: a randomized, double-blind, parallel-group controlled trial. J Allergy Clin Immunol. 1992 Jul;90(1):32–42. doi: 10.1016/s0091-6749(06)80008-4. [DOI] [PubMed] [Google Scholar]
  76. Lang Z., Murlas C. G. Dexamethasone increases airway epithelial cell neutral endopeptidase by enhancing transcription and new protein synthesis. Lung. 1993;171(3):161–172. doi: 10.1007/BF00183945. [DOI] [PubMed] [Google Scholar]
  77. LeVan T. D., Behr F. D., Adkins K. K., Miesfeld R. L., Bloom J. W. Glucocorticoid receptor signaling in a bronchial epithelial cell line. Am J Physiol. 1997 May;272(5 Pt 1):L838–L843. doi: 10.1152/ajplung.1997.272.5.L838. [DOI] [PubMed] [Google Scholar]
  78. Lebeau M. C., Massol N., Herrick J., Faber L. E., Renoir J. M., Radanyi C., Baulieu E. E. P59, an hsp 90-binding protein. Cloning and sequencing of its cDNA and preparation of a peptide-directed polyclonal antibody. J Biol Chem. 1992 Mar 5;267(7):4281–4284. [PubMed] [Google Scholar]
  79. Lee S. W., Tsou A. P., Chan H., Thomas J., Petrie K., Eugui E. M., Allison A. C. Glucocorticoids selectively inhibit the transcription of the interleukin 1 beta gene and decrease the stability of interleukin 1 beta mRNA. Proc Natl Acad Sci U S A. 1988 Feb;85(4):1204–1208. doi: 10.1073/pnas.85.4.1204. [DOI] [PMC free article] [PubMed] [Google Scholar]
  80. Lenardo M. J., Baltimore D. NF-kappa B: a pleiotropic mediator of inducible and tissue-specific gene control. Cell. 1989 Jul 28;58(2):227–229. doi: 10.1016/0092-8674(89)90833-7. [DOI] [PubMed] [Google Scholar]
  81. Levine S. J., Benfield T., Shelhamer J. H. Corticosteroids induce intracellular interleukin-1 receptor antagonist type I expression by a human airway epithelial cell line. Am J Respir Cell Mol Biol. 1996 Aug;15(2):245–251. doi: 10.1165/ajrcmb.15.2.8703481. [DOI] [PubMed] [Google Scholar]
  82. Levine S. J., Larivée P., Logun C., Angus C. W., Shelhamer J. H. Corticosteroids differentially regulate secretion of IL-6, IL-8, and G-CSF by a human bronchial epithelial cell line. Am J Physiol. 1993 Oct;265(4 Pt 1):L360–L368. doi: 10.1152/ajplung.1993.265.4.L360. [DOI] [PubMed] [Google Scholar]
  83. Levine S. J., Logun C., Chopra D. P., Rhim J. S., Shelhamer J. H. Protein kinase C, interleukin-1 beta, and corticosteroids regulate shedding of the type I, 55 kDa TNF receptor from human airway epithelial cells. Am J Respir Cell Mol Biol. 1996 Mar;14(3):254–261. doi: 10.1165/ajrcmb.14.3.8845176. [DOI] [PubMed] [Google Scholar]
  84. Lilly C. M., Nakamura H., Kesselman H., Nagler-Anderson C., Asano K., Garcia-Zepeda E. A., Rothenberg M. E., Drazen J. M., Luster A. D. Expression of eotaxin by human lung epithelial cells: induction by cytokines and inhibition by glucocorticoids. J Clin Invest. 1997 Apr 1;99(7):1767–1773. doi: 10.1172/JCI119341. [DOI] [PMC free article] [PubMed] [Google Scholar]
  85. Lopez A. F., Williamson D. J., Gamble J. R., Begley C. G., Harlan J. M., Klebanoff S. J., Waltersdorph A., Wong G., Clark S. C., Vadas M. A. Recombinant human granulocyte-macrophage colony-stimulating factor stimulates in vitro mature human neutrophil and eosinophil function, surface receptor expression, and survival. J Clin Invest. 1986 Nov;78(5):1220–1228. doi: 10.1172/JCI112705. [DOI] [PMC free article] [PubMed] [Google Scholar]
  86. Luisi B. F., Xu W. X., Otwinowski Z., Freedman L. P., Yamamoto K. R., Sigler P. B. Crystallographic analysis of the interaction of the glucocorticoid receptor with DNA. Nature. 1991 Aug 8;352(6335):497–505. doi: 10.1038/352497a0. [DOI] [PubMed] [Google Scholar]
  87. Lundgren J. D., Hirata F., Marom Z., Logun C., Steel L., Kaliner M., Shelhamer J. Dexamethasone inhibits respiratory glycoconjugate secretion from feline airways in vitro by the induction of lipocortin (lipomodulin) synthesis. Am Rev Respir Dis. 1988 Feb;137(2):353–357. doi: 10.1164/ajrccm/137.2.353. [DOI] [PubMed] [Google Scholar]
  88. Lundgren R. Scanning electron microscopic studies of bronchial mucosa before and during treatment with beclomethasone dipropionate inhalations. Scand J Respir Dis Suppl. 1977;101:179–187. [PubMed] [Google Scholar]
  89. Mak J. C., Nishikawa M., Shirasaki H., Miyayasu K., Barnes P. J. Protective effects of a glucocorticoid on downregulation of pulmonary beta 2-adrenergic receptors in vivo. J Clin Invest. 1995 Jul;96(1):99–106. doi: 10.1172/JCI118084. [DOI] [PMC free article] [PubMed] [Google Scholar]
  90. Mansoor A. M., Honda M., Saida K., Ishinaga Y., Kuramochi T., Maeda A., Takabatake T., Mitsui Y. Endothelin induced collagen remodeling in experimental pulmonary hypertension. Biochem Biophys Res Commun. 1995 Oct 24;215(3):981–986. doi: 10.1006/bbrc.1995.2560. [DOI] [PubMed] [Google Scholar]
  91. Marini M., Vittori E., Hollemborg J., Mattoli S. Expression of the potent inflammatory cytokines, granulocyte-macrophage-colony-stimulating factor and interleukin-6 and interleukin-8, in bronchial epithelial cells of patients with asthma. J Allergy Clin Immunol. 1992 May;89(5):1001–1009. doi: 10.1016/0091-6749(92)90223-o. [DOI] [PubMed] [Google Scholar]
  92. Martin G. L., Atkins P. C., Dunsky E. H., Zweiman B. Effects of theophylline, terbutaline, and prednisone on antigen-induced bronchospasm and mediator release. J Allergy Clin Immunol. 1980 Sep;66(3):204–212. doi: 10.1016/0091-6749(80)90040-8. [DOI] [PubMed] [Google Scholar]
  93. Mattoli S., Mezzetti M., Riva G., Allegra L., Fasoli A. Specific binding of endothelin on human bronchial smooth muscle cells in culture and secretion of endothelin-like material from bronchial epithelial cells. Am J Respir Cell Mol Biol. 1990 Aug;3(2):145–151. doi: 10.1165/ajrcmb/3.2.145. [DOI] [PubMed] [Google Scholar]
  94. Mendel D. B., Ortí E. Isoform composition and stoichiometry of the approximately 90-kDa heat shock protein associated with glucocorticoid receptors. J Biol Chem. 1988 May 15;263(14):6695–6702. [PubMed] [Google Scholar]
  95. Mitchell J. A., Belvisi M. G., Akarasereenont P., Robbins R. A., Kwon O. J., Croxtall J., Barnes P. J., Vane J. R. Induction of cyclo-oxygenase-2 by cytokines in human pulmonary epithelial cells: regulation by dexamethasone. Br J Pharmacol. 1994 Nov;113(3):1008–1014. doi: 10.1111/j.1476-5381.1994.tb17093.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  96. Montefort S., Herbert C. A., Robinson C., Holgate S. T. The bronchial epithelium as a target for inflammatory attack in asthma. Clin Exp Allergy. 1992 May;22(5):511–520. doi: 10.1111/j.1365-2222.1992.tb00159.x. [DOI] [PubMed] [Google Scholar]
  97. Mukaida N., Morita M., Ishikawa Y., Rice N., Okamoto S., Kasahara T., Matsushima K. Novel mechanism of glucocorticoid-mediated gene repression. Nuclear factor-kappa B is target for glucocorticoid-mediated interleukin 8 gene repression. J Biol Chem. 1994 May 6;269(18):13289–13295. [PubMed] [Google Scholar]
  98. Möller G. M., Overbeek S. E., Van Helden-Meeuwsen C. G., Van Haarst J. M., Prens E. P., Mulder P. G., Postma D. S., Hoogsteden H. C. Increased numbers of dendritic cells in the bronchial mucosa of atopic asthmatic patients: downregulation by inhaled corticosteroids. Clin Exp Allergy. 1996 May;26(5):517–524. [PubMed] [Google Scholar]
  99. Nadel J. A., Borson D. B. Modulation of neurogenic inflammation by neutral endopeptidase. Am Rev Respir Dis. 1991 Mar;143(3 Pt 2):S33–S36. doi: 10.1164/ajrccm/143.3_Pt_2.S33. [DOI] [PubMed] [Google Scholar]
  100. Nakamura Y., Azuma M., Okano Y., Sano T., Takahashi T., Ohmoto Y., Sone S. Upregulatory effects of interleukin-4 and interleukin-13 but not interleukin-10 on granulocyte/macrophage colony-stimulating factor production by human bronchial epithelial cells. Am J Respir Cell Mol Biol. 1996 Nov;15(5):680–687. doi: 10.1165/ajrcmb.15.5.8918375. [DOI] [PubMed] [Google Scholar]
  101. Naseer T., Minshall E. M., Leung D. Y., Laberge S., Ernst P., Martin R. J., Hamid Q. Expression of IL-12 and IL-13 mRNA in asthma and their modulation in response to steroid therapy. Am J Respir Crit Care Med. 1997 Mar;155(3):845–851. doi: 10.1164/ajrccm.155.3.9117015. [DOI] [PubMed] [Google Scholar]
  102. Oakley R. H., Webster J. C., Sar M., Parker C. R., Jr, Cidlowski J. A. Expression and subcellular distribution of the beta-isoform of the human glucocorticoid receptor. Endocrinology. 1997 Nov;138(11):5028–5038. doi: 10.1210/endo.138.11.5501. [DOI] [PubMed] [Google Scholar]
  103. Olivieri D., Chetta A., Del Donno M., Bertorelli G., Casalini A., Pesci A., Testi R., Foresi A. Effect of short-term treatment with low-dose inhaled fluticasone propionate on airway inflammation and remodeling in mild asthma: a placebo-controlled study. Am J Respir Crit Care Med. 1997 Jun;155(6):1864–1871. doi: 10.1164/ajrccm.155.6.9196087. [DOI] [PubMed] [Google Scholar]
  104. Osterman K., Carlholm M., Ekelund J., Kiviloog J., Nikander K., Nilholm L., Salomonsson P., Strand V., Venge P., Zetterström O. Effect of 1 year daily treatment with 400 microg budesonide (Pulmicort Turbuhaler) in newly diagnosed asthmatics. Eur Respir J. 1997 Oct;10(10):2210–2215. doi: 10.1183/09031936.97.10102210. [DOI] [PubMed] [Google Scholar]
  105. Otto C., Reichardt H. M., Schütz G. Absence of glucocorticoid receptor-beta in mice. J Biol Chem. 1997 Oct 17;272(42):26665–26668. doi: 10.1074/jbc.272.42.26665. [DOI] [PubMed] [Google Scholar]
  106. Owen W. F., Rothenberg M. E., Petersen J., Weller P. F., Silberstein D., Sheffer A. L., Stevens R. L., Soberman R. J., Austen K. F. Interleukin 5 and phenotypically altered eosinophils in the blood of patients with the idiopathic hypereosinophilic syndrome. J Exp Med. 1989 Jul 1;170(1):343–348. doi: 10.1084/jem.170.1.343. [DOI] [PMC free article] [PubMed] [Google Scholar]
  108. doi: 10.1098/rspb.1997.0118. [DOI] [PMC free article] [Google Scholar]
  109. Paolieri F., Battifora M., Riccio A. M., Ciprandi G., Scordamaglia A., Morelli C., Bagnasco M., Canonica G. W. Inhibition of adhesion molecules by budesonide on a human epithelial cell line (lung carcinoma). Allergy. 1997 Sep;52(9):935–943. doi: 10.1111/j.1398-9995.1997.tb01254.x. [DOI] [PubMed] [Google Scholar]
  110. Parker M. Enhancer elements activated by steroid hormones? Nature. 1983 Aug 25;304(5928):687–688. doi: 10.1038/304687a0. [DOI] [PubMed] [Google Scholar]
  111. Peppel K., Vinci J. M., Baglioni C. The AU-rich sequences in the 3' untranslated region mediate the increased turnover of interferon mRNA induced by glucocorticoids. J Exp Med. 1991 Feb 1;173(2):349–355. doi: 10.1084/jem.173.2.349. [DOI] [PMC free article] [PubMed] [Google Scholar]
  112. Perlmann T., Wrange O. Specific glucocorticoid receptor binding to DNA reconstituted in a nucleosome. EMBO J. 1988 Oct;7(10):3073–3079. doi: 10.1002/j.1460-2075.1988.tb03172.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  113. Peters M. J., Adcock I. M., Brown C. R., Barnes P. J. Beta-adrenoceptor agonists interfere with glucocorticoid receptor DNA binding in rat lung. Eur J Pharmacol. 1995 Apr 28;289(2):275–281. doi: 10.1016/0922-4106(95)90104-3. [DOI] [PubMed] [Google Scholar]
  114. Picard D., Yamamoto K. R. Two signals mediate hormone-dependent nuclear localization of the glucocorticoid receptor. EMBO J. 1987 Nov;6(11):3333–3340. doi: 10.1002/j.1460-2075.1987.tb02654.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  115. Rakasz E., Gal A., Biró J., Balas G., Falus A. Modulation of glucocorticosteroid binding in human lymphoid, monocytoid and hepatoma cell lines by inflammatory cytokines interleukin (IL)-1 beta, IL-6 and tumour necrosis factor (TNF)-alpha. Scand J Immunol. 1993 Jun;37(6):684–689. doi: 10.1111/j.1365-3083.1993.tb01684.x. [DOI] [PubMed] [Google Scholar]
  116. Ransone L. J., Verma I. M. Nuclear proto-oncogenes fos and jun. Annu Rev Cell Biol. 1990;6:539–557. doi: 10.1146/annurev.cb.06.110190.002543. [DOI] [PubMed] [Google Scholar]
  117. Ray A., Prefontaine K. E. Physical association and functional antagonism between the p65 subunit of transcription factor NF-kappa B and the glucocorticoid receptor. Proc Natl Acad Sci U S A. 1994 Jan 18;91(2):752–756. doi: 10.1073/pnas.91.2.752. [DOI] [PMC free article] [PubMed] [Google Scholar]
  118. Re F., Muzio M., De Rossi M., Polentarutti N., Giri J. G., Mantovani A., Colotta F. The type II "receptor" as a decoy target for interleukin 1 in polymorphonuclear leukocytes: characterization of induction by dexamethasone and ligand binding properties of the released decoy receptor. J Exp Med. 1994 Feb 1;179(2):739–743. doi: 10.1084/jem.179.2.739. [DOI] [PMC free article] [PubMed] [Google Scholar]
  119. Redington A. E., Springall D. R., Meng Q. H., Tuck A. B., Holgate S. T., Polak J. M., Howarth P. H. Immunoreactive endothelin in bronchial biopsy specimens: increased expression in asthma and modulation by corticosteroid therapy. J Allergy Clin Immunol. 1997 Oct;100(4):544–552. doi: 10.1016/s0091-6749(97)70148-9. [DOI] [PubMed] [Google Scholar]
  120. Rizvi M. A., Katwa L., Spadone D. P., Myers P. R. The effects of endothelin-1 on collagen type I and type III synthesis in cultured porcine coronary artery vascular smooth muscle cells. J Mol Cell Cardiol. 1996 Feb;28(2):243–252. doi: 10.1006/jmcc.1996.0023. [DOI] [PubMed] [Google Scholar]
  121. Robbins R. A., Barnes P. J., Springall D. R., Warren J. B., Kwon O. J., Buttery L. D., Wilson A. J., Geller D. A., Polak J. M. Expression of inducible nitric oxide in human lung epithelial cells. Biochem Biophys Res Commun. 1994 Aug 30;203(1):209–218. doi: 10.1006/bbrc.1994.2169. [DOI] [PubMed] [Google Scholar]
  122. Robinson D. S., Assoufi B., Durham S. R., Kay A. B. Eosinophil cationic protein (ECP) and eosinophil protein X (EPX) concentrations in serum and bronchial lavage fluid in asthma. Effect of prednisolone treatment. Clin Exp Allergy. 1995 Nov;25(11):1118–1127. doi: 10.1111/j.1365-2222.1995.tb03259.x. [DOI] [PubMed] [Google Scholar]
  123. Robinson D., Hamid Q., Bentley A., Ying S., Kay A. B., Durham S. R. Activation of CD4+ T cells, increased TH2-type cytokine mRNA expression, and eosinophil recruitment in bronchoalveolar lavage after allergen inhalation challenge in patients with atopic asthma. J Allergy Clin Immunol. 1993 Aug;92(2):313–324. doi: 10.1016/0091-6749(93)90175-f. [DOI] [PubMed] [Google Scholar]
  124. Rosewicz S., McDonald A. R., Maddux B. A., Goldfine I. D., Miesfeld R. L., Logsdon C. D. Mechanism of glucocorticoid receptor down-regulation by glucocorticoids. J Biol Chem. 1988 Feb 25;263(6):2581–2584. [PubMed] [Google Scholar]
  125. Rothenberg M. E., Owen W. F., Jr, Silberstein D. S., Woods J., Soberman R. J., Austen K. F., Stevens R. L. Human eosinophils have prolonged survival, enhanced functional properties, and become hypodense when exposed to human interleukin 3. J Clin Invest. 1988 Jun;81(6):1986–1992. doi: 10.1172/JCI113547. [DOI] [PMC free article] [PubMed] [Google Scholar]
  126. Rusconi S., Yamamoto K. R. Functional dissection of the hormone and DNA binding activities of the glucocorticoid receptor. EMBO J. 1987 May;6(5):1309–1315. doi: 10.1002/j.1460-2075.1987.tb02369.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  127. Salkowski C. A., Vogel S. N. IFN-gamma mediates increased glucocorticoid receptor expression in murine macrophages. J Immunol. 1992 May 1;148(9):2770–2777. [PubMed] [Google Scholar]
  128. Salkowski C. A., Vogel S. N. Lipopolysaccharide increases glucocorticoid receptor expression in murine macrophages. A possible mechanism for glucocorticoid-mediated suppression of endotoxicity. J Immunol. 1992 Dec 15;149(12):4041–4047. [PubMed] [Google Scholar]
  129. Sanchez E. R. Hsp56: a novel heat shock protein associated with untransformed steroid receptor complexes. J Biol Chem. 1990 Dec 25;265(36):22067–22070. [PubMed] [Google Scholar]
  130. Sato M., Takizawa H., Kohyama T., Ohtoshi T., Takafuji S., Kawasaki S., Tohma S., Ishii A., Shoji S., Ito K. Eosinophil adhesion to human bronchial epithelial cells: regulation by cytokines. Int Arch Allergy Immunol. 1997 May-Jul;113(1-3):203–205. doi: 10.1159/000237547. [DOI] [PubMed] [Google Scholar]
  131. Schalkwijk C., Vervoordeldonk M., Pfeilschifter J., Märki F., van den Bosch H. Cytokine- and forskolin-induced synthesis of group II phospholipase A2 and prostaglandin E2 in rat mesangial cells is prevented by dexamethasone. Biochem Biophys Res Commun. 1991 Oct 15;180(1):46–52. doi: 10.1016/s0006-291x(05)81252-5. [DOI] [PubMed] [Google Scholar]
  132. Scheinman R. I., Cogswell P. C., Lofquist A. K., Baldwin A. S., Jr Role of transcriptional activation of I kappa B alpha in mediation of immunosuppression by glucocorticoids. Science. 1995 Oct 13;270(5234):283–286. doi: 10.1126/science.270.5234.283. [DOI] [PubMed] [Google Scholar]
  133. Schena M., Freedman L. P., Yamamoto K. R. Mutations in the glucocorticoid receptor zinc finger region that distinguish interdigitated DNA binding and transcriptional enhancement activities. Genes Dev. 1989 Oct;3(10):1590–1601. doi: 10.1101/gad.3.10.1590. [DOI] [PubMed] [Google Scholar]
  134. Schleimer R. P. Effects of glucocorticosteroids on inflammatory cells relevant to their therapeutic applications in asthma. Am Rev Respir Dis. 1990 Feb;141(2 Pt 2):S59–S69. [PubMed] [Google Scholar]
  135. Schleimer R. P., Schulman E. S., MacGlashan D. W., Jr, Peters S. P., Hayes E. C., Adams G. K., 3rd, Lichtenstein L. M., Adkinson N. F., Jr Effects of dexamethasone on mediator release from human lung fragments and purified human lung mast cells. J Clin Invest. 1983 Jun;71(6):1830–1835. doi: 10.1172/JCI110938. [DOI] [PMC free article] [PubMed] [Google Scholar]
  136. Schüle R., Rangarajan P., Kliewer S., Ransone L. J., Bolado J., Yang N., Verma I. M., Evans R. M. Functional antagonism between oncoprotein c-Jun and the glucocorticoid receptor. Cell. 1990 Sep 21;62(6):1217–1226. doi: 10.1016/0092-8674(90)90397-w. [DOI] [PubMed] [Google Scholar]
  137. Shimura S., Sasaki T., Ikeda K., Yamauchi K., Sasaki H., Takishima T. Direct inhibitory action of glucocorticoid on glycoconjugate secretion from airway submucosal glands. Am Rev Respir Dis. 1990 Apr;141(4 Pt 1):1044–1049. doi: 10.1164/ajrccm/141.4_Pt_1.1044. [DOI] [PubMed] [Google Scholar]
  138. Siebenlist U., Franzoso G., Brown K. Structure, regulation and function of NF-kappa B. Annu Rev Cell Biol. 1994;10:405–455. doi: 10.1146/annurev.cb.10.110194.002201. [DOI] [PubMed] [Google Scholar]
  139. Simons F. E. A comparison of beclomethasone, salmeterol, and placebo in children with asthma. Canadian Beclomethasone Dipropionate-Salmeterol Xinafoate Study Group. N Engl J Med. 1997 Dec 4;337(23):1659–1665. doi: 10.1056/NEJM199712043372304. [DOI] [PubMed] [Google Scholar]
  140. Smith D. F., Stensgard B. A., Welch W. J., Toft D. O. Assembly of progesterone receptor with heat shock proteins and receptor activation are ATP mediated events. J Biol Chem. 1992 Jan 15;267(2):1350–1356. [PubMed] [Google Scholar]
  141. Snyers L., De Wit L., Content J. Glucocorticoid up-regulation of high-affinity interleukin 6 receptors on human epithelial cells. Proc Natl Acad Sci U S A. 1990 Apr;87(7):2838–2842. doi: 10.1073/pnas.87.7.2838. [DOI] [PMC free article] [PubMed] [Google Scholar]
  142. Sont J. K., van Krieken J. H., van Klink H. C., Roldaan A. C., Apap C. R., Willems L. N., Sterk P. J. Enhanced expression of neutral endopeptidase (NEP) in airway epithelium in biopsies from steroid- versus nonsteroid-treated patients with atopic asthma. Am J Respir Cell Mol Biol. 1997 May;16(5):549–556. doi: 10.1165/ajrcmb.16.5.9160837. [DOI] [PubMed] [Google Scholar]
  143. Sousa A. R., Poston R. N., Lane S. J., Nakhosteen J. A., Lee T. H. Detection of GM-CSF in asthmatic bronchial epithelium and decrease by inhaled corticosteroids. Am Rev Respir Dis. 1993 Jun;147(6 Pt 1):1557–1561. doi: 10.1164/ajrccm/147.6_Pt_1.1557. [DOI] [PubMed] [Google Scholar]
  144. Sousa A. R., Trigg C. J., Lane S. J., Hawksworth R., Nakhosteen J. A., Poston R. N., Lee T. H. Effect of inhaled glucocorticoids on IL-1 beta and IL-1 receptor antagonist (IL-1 ra) expression in asthmatic bronchial epithelium. Thorax. 1997 May;52(5):407–410. doi: 10.1136/thx.52.5.407. [DOI] [PMC free article] [PubMed] [Google Scholar]
  145. Springall D. R., Howarth P. H., Counihan H., Djukanovic R., Holgate S. T., Polak J. M. Endothelin immunoreactivity of airway epithelium in asthmatic patients. Lancet. 1991 Mar 23;337(8743):697–701. doi: 10.1016/0140-6736(91)90279-x. [DOI] [PubMed] [Google Scholar]
  146. Stellato C., Beck L. A., Gorgone G. A., Proud D., Schall T. J., Ono S. J., Lichtenstein L. M., Schleimer R. P. Expression of the chemokine RANTES by a human bronchial epithelial cell line. Modulation by cytokines and glucocorticoids. J Immunol. 1995 Jul 1;155(1):410–418. [PubMed] [Google Scholar]
  147. Strähle U., Schmid W., Schütz G. Synergistic action of the glucocorticoid receptor with transcription factors. EMBO J. 1988 Nov;7(11):3389–3395. doi: 10.1002/j.1460-2075.1988.tb03212.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  148. Takizawa H., Ohtoshi T., Yamashita N., Oka T., Ito K. Interleukin 6-receptor expression on human bronchial epithelial cells: regulation by IL-1 and IL-6. Am J Physiol. 1996 Mar;270(3 Pt 1):L346–L352. doi: 10.1152/ajplung.1996.270.3.L346. [DOI] [PubMed] [Google Scholar]
  149. Tan S., Hall I. P., Dewar J., Dow E., Lipworth B. Association between beta 2-adrenoceptor polymorphism and susceptibility to bronchodilator desensitisation in moderately severe stable asthmatics. Lancet. 1997 Oct 4;350(9083):995–999. doi: 10.1016/S0140-6736(97)03211-X. [DOI] [PubMed] [Google Scholar]
  150. Trigg C. J., Manolitsas N. D., Wang J., Calderón M. A., McAulay A., Jordan S. E., Herdman M. J., Jhalli N., Duddle J. M., Hamilton S. A. Placebo-controlled immunopathologic study of four months of inhaled corticosteroids in asthma. Am J Respir Crit Care Med. 1994 Jul;150(1):17–22. doi: 10.1164/ajrccm.150.1.8025745. [DOI] [PubMed] [Google Scholar]
  151. Truss M., Beato M. Steroid hormone receptors: interaction with deoxyribonucleic acid and transcription factors. Endocr Rev. 1993 Aug;14(4):459–479. doi: 10.1210/edrv-14-4-459. [DOI] [PubMed] [Google Scholar]
  152. Van Hal P. T., Overbeek S. E., Hoogsteden H. C., Zijlstra F. J., Murphy K., Oosterhoff Y., Postma D. S., Guz A., Smith S. F. Eicosanoids and lipocortin-1 in BAL fluid in asthma: effects of smoking and inhaled glucocorticoids. J Appl Physiol (1985) 1996 Aug;81(2):548–555. doi: 10.1152/jappl.1996.81.2.548. [DOI] [PubMed] [Google Scholar]
  153. Van de Graaf E. A., Out T. A., Roos C. M., Jansen H. M. Respiratory membrane permeability and bronchial hyperreactivity in patients with stable asthma. Effects of therapy with inhaled steroids. Am Rev Respir Dis. 1991 Feb;143(2):362–368. doi: 10.1164/ajrccm/143.2.362. [DOI] [PubMed] [Google Scholar]
  154. Verheggen M. M., van Hal P. T., Adriaansen-Soeting P. W., Goense B. J., Hoogsteden H. C., Brinkmann A. O., Versnel M. A. Modulation of glucocorticoid receptor expression in human bronchial epithelial cell lines by IL-1 beta, TNF-alpha and LPS. Eur Respir J. 1996 Oct;9(10):2036–2043. doi: 10.1183/09031936.96.09102036. [DOI] [PubMed] [Google Scholar]
  155. Vittori E., Marini M., Fasoli A., De Franchis R., Mattoli S. Increased expression of endothelin in bronchial epithelial cells of asthmatic patients and effect of corticosteroids. Am Rev Respir Dis. 1992 Nov;146(5 Pt 1):1320–1325. doi: 10.1164/ajrccm/146.5_Pt_1.1320. [DOI] [PubMed] [Google Scholar]
  156. Wallner B. P., Mattaliano R. J., Hession C., Cate R. L., Tizard R., Sinclair L. K., Foeller C., Chow E. P., Browing J. L., Ramachandran K. L. Cloning and expression of human lipocortin, a phospholipase A2 inhibitor with potential anti-inflammatory activity. Nature. 1986 Mar 6;320(6057):77–81. doi: 10.1038/320077a0. [DOI] [PubMed] [Google Scholar]
  157. Wang J. H., Devalia J. L., Xia C., Sapsford R. J., Davies R. J. Expression of RANTES by human bronchial epithelial cells in vitro and in vivo and the effect of corticosteroids. Am J Respir Cell Mol Biol. 1996 Jan;14(1):27–35. doi: 10.1165/ajrcmb.14.1.8534483. [DOI] [PubMed] [Google Scholar]
  158. Wardlaw A. J., Kay A. B. The role of the eosinophil in the pathogenesis of asthma. Allergy. 1987 Jul;42(5):321–335. doi: 10.1111/j.1398-9995.1987.tb02218.x. [DOI] [PubMed] [Google Scholar]
  159. Xie Q. W., Kashiwabara Y., Nathan C. Role of transcription factor NF-kappa B/Rel in induction of nitric oxide synthase. J Biol Chem. 1994 Feb 18;269(7):4705–4708. [PubMed] [Google Scholar]
  160. Yamamoto K. K., Gonzalez G. A., Menzel P., Rivier J., Montminy M. R. Characterization of a bipartite activator domain in transcription factor CREB. Cell. 1990 Feb 23;60(4):611–617. doi: 10.1016/0092-8674(90)90664-z. [DOI] [PubMed] [Google Scholar]
  161. Yang-Yen H. F., Chambard J. C., Sun Y. L., Smeal T., Schmidt T. J., Drouin J., Karin M. Transcriptional interference between c-Jun and the glucocorticoid receptor: mutual inhibition of DNA binding due to direct protein-protein interaction. Cell. 1990 Sep 21;62(6):1205–1215. doi: 10.1016/0092-8674(90)90396-v. [DOI] [PubMed] [Google Scholar]
  162. Zaret K. S., Yamamoto K. R. Reversible and persistent changes in chromatin structure accompany activation of a glucocorticoid-dependent enhancer element. Cell. 1984 Aug;38(1):29–38. doi: 10.1016/0092-8674(84)90523-3. [DOI] [PubMed] [Google Scholar]
  163. de Waal R. M. The anti-inflammatory activity of glucocorticoids. Mol Biol Rep. 1994 Mar;19(2):81–88. doi: 10.1007/BF00997151. [DOI] [PubMed] [Google Scholar]
  164. van de Stolpe A., Caldenhoven E., Raaijmakers J. A., van der Saag P. T., Koenderman L. Glucocorticoid-mediated repression of intercellular adhesion molecule-1 expression in human monocytic and bronchial epithelial cell lines. Am J Respir Cell Mol Biol. 1993 Mar;8(3):340–347. doi: 10.1165/ajrcmb/8.3.340. [DOI] [PubMed] [Google Scholar]
  165. van der Velden V. H., Naber B. A., van der Spoel P., Hoogsteden H. C., Versnel M. A. Cytokines and glucocorticoids modulate human bronchial epithelial cell peptidases. Cytokine. 1998 Jan;10(1):55–65. doi: 10.1006/cyto.1997.0257. [DOI] [PubMed] [Google Scholar]

Articles from Mediators of Inflammation are provided here courtesy of Wiley

RESOURCES